Henrik Rieß

graph of relations

Publications

  1. 2013
  2. Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study

    Sinn, M., Nicolaou, A., Gebauer, B., Podrabsky, P., Seehofer, D., Ricke, J., Dörken, B., Riess, H. & Hildebrandt, B., 08.2013, In: DIGEST DIS SCI. 58, 8, p. 2399-405 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Blood group determinates incidence for pancreatic cancer in Germany

    Pelzer, U., Klein, F., Bahra, M., Sinn, M., Dörken, B., Neuhaus, P., Meyer, O. & Riess, H., 2013, In: FRONT PHYSIOL. 4, p. 118

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. 2012
  5. High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer.

    Klauschen, F., von, W. M., Stenzinger, A., Sinn, BV., Budczies, J., Kamphues, C., Bahra, M., Wittschieber, D., Weichert, W., Striefler, J., Riess, H., Dietel, M. & Denkert, C., 2012, In: HISTOPATHOLOGY.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 Next